Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 3/20 | 0.50 |
| ▸ | AKR1C2 | P52895 | 3/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 2/20 | 0.36 |
| ▸ | CES1 | P23141 | 2/20 | 0.36 |
| ▸ | ESR1 | P03372 | 2/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.36 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | F2 | P00734 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | PARP1 | P09874 | 1/20 | 0.34 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.34 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21585232 | 0.81 | CYP4F2 (0.52) | PKMCYP4F2CYP4A11NPC1RAB9A | |
| SCHEMBL1169066 | 0.80 | AKR1C3 (0.72) | AKR1C3AKR1C2PTGS1PTGS2TAS2R14 | |
| SCHEMBL1195462 | 0.78 | AKR1C3 (0.51) | AKR1C3AKR1C2PTGS1PTGS2TAS2R14 | |
| SCHEMBL477610 | 0.78 | AKR1C3 (0.51) | AKR1C3AKR1C2PTGS1PTGS2TAS2R14 | |
| SCHEMBL20560502 | 0.75 | AKR1C3 (0.39) | AKR1C3AKR1C2PTGS1ESR1ESR2 | |
| SCHEMBL1194372 | 0.74 | GSK3B (0.52) | AKR1C3AKR1C2PTGS1PTGS2TAS2R14 | |
| SCHEMBL23430506 | 0.74 | KMT2A (0.54) | AKR1C3AKR1C2ESR1ESR2PKM | |
| SCHEMBL5649611 | 0.74 | CES2 (0.65) | CES2CES1ESR1ESR2PKM | |
| SCHEMBL545343 | 0.73 | LMNA (0.58) | AKR1C3CES2CES1F2LMNA | |
| Isophthalic Acid SCHEMBL20500517 | 0.71 | CA12 (0.56) | AKR1C3PKMKMT2ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116354830-A | Process for the preparation of functionalized fluorinated monomers, fluorinated monomers and compositions for the preparation thereof | 埃特纳科技有限公司 | 2023-06-30 | — | — | CN | disclosed |
| CN-110770271-B | Method for preparing functionalized fluorinated monomers, fluorinated monomers and compositions for preparing same | 埃特纳科技有限公司 | 2023-04-18 | — | — | CN | disclosed |
| US-20220213016-A1 | Methods for Making Functionalized Fluorinated Monomers, Fluorinated Monomers, and Compositions for Making the Same | ETNA-TEC, LTD. | 2022-07-07 | — | — | US | disclosed |
| EP-3635022-A1 | METHODS FOR MAKING FUNCTIONALIZED FLUORINATED MONOMERS, FLUORINATED MONOMERS, AND COMPOSITIONS FOR MAKING THE SAME | Etna-Tec, Ltd (US) | 2020-04-15 | — | — | EP | disclosed |
| CN-110770271-A | Method for preparing functionalized fluorinated monomers, fluorinated monomers and compositions for preparing same | 埃特纳科技有限公司 | 2020-02-07 | — | — | CN | disclosed |
| US-20180334416-A1 | Methods for Making Functionalized Fluorinated Monomers, Fluorinated Monomers, and Compositions for Making the Same | ETNA-TEC, LTD. | 2018-11-22 | — | — | US | disclosed |
| WO-2018213850-A1 | METHODS FOR MAKING FUNCTIONALIZED FLUORINATED MONOMERS, FLUORINATED MONOMERS, AND COMPOSITIONS FOR MAKING THE SAME | ETNA-TEC, LTD (US) | 2018-11-22 | — | — | WO | disclosed |
| US-20180334417-A1 | Methods for Making Functionalized Fluorinated Monomers, Fluorinated Monomers, and Compositions for Making the Same | ETNA-TEC, LTD. | 2018-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180334417-A1 | Methods for Making Functionalized Fluorinated Monomers, Fluorinated Monomers, and Compositions for Making the Same | ALKBH3, FTO, THEM6 | AKR1C3 376/4885AKR1C2 304/4885PTGS1 2145/4885 |
| US-20220213016-A1 | Methods for Making Functionalized Fluorinated Monomers, Fluorinated Monomers, and Compositions for Making the Same | ALKBH3, FTO, ALK | AKR1C3 373/4885AKR1C2 302/4885PTGS1 2188/4885 |
| US-20180334416-A1 | Methods for Making Functionalized Fluorinated Monomers, Fluorinated Monomers, and Compositions for Making the Same | ALKBH3, FTO, ALK | AKR1C3 373/4885AKR1C2 302/4885PTGS1 2188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.